Baker Brothers Life Sciences Capital (GP), LLC Insider Trading $SGEN Seagen Inc.
Get free email notifications about insider trading for Baker Brothers Life Sciences Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Brothers Life Sciences Capital (GP), LLC. Baker Brothers Life Sciences Capital (GP), LLC is Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and 10% Owner in TAPESTRY PHARMACEUTICALS, INC ($NPRO) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Baker Brothers Life Sciences Capital (GP), LLC in Seagen Inc.
Trading Symbol: SGENIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Brothers Life Sciences Capital (GP), LLC: Director
Holdings: 4,149,611 shares
Current Value: $252,254,853
Latest Transaction: Aug 16 2006
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker Brothers Life Sciences Capital (GP), LLC in Seagen Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IBPI, AUXL, GHDX, IDRA, INCY, NRGN, SGEN, GEVA, NPRO
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 16 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.05 | 37,070 | 150,134 | 4,149,611 | 4.1 M to 4.1 M (+0.90 %) |
Aug 15 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.03 | 106,622 | 429,591 | 4,112,541 | 4 M to 4.1 M (+2.66 %) |
Aug 15 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.03 | 2,559 | 10,313 | 4,005,919 | 4 M to 4 M (+0.06 %) |
Aug 15 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.04 | 1,038 | 4,190 | 4,003,360 | 4 M to 4 M (+0.03 %) |
Aug 15 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 3.70 | 23,576 | 87,208 | 3,734,541 | 3.7 M to 3.7 M (+0.64 %) |
Aug 10 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.05 | 36,328 | 147,125 | 3,978,746 | 3.9 M to 4 M (+0.92 %) |
Aug 10 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.05 | 159,019 | 644,027 | 3,942,418 | 3.8 M to 3.9 M (+4.20 %) |
Aug 10 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.05 | 7,414 | 30,010 | 3,783,399 | 3.8 M to 3.8 M (+0.20 %) |
Aug 08 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.03 | 28,692 | 115,746 | 3,775,985 | 3.7 M to 3.8 M (+0.77 %) |
Aug 08 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.05 | 17,793 | 72,058 | 3,747,293 | 3.7 M to 3.7 M (+0.48 %) |
Aug 08 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.00 | 18,535 | 74,079 | 3,729,500 | 3.7 M to 3.7 M (+0.50 %) |
Jun 29 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.08 | 61,443 | 250,491 | 3,710,965 | 3.6 M to 3.7 M (+1.68 %) |
Jun 29 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.02 | 233,645 | 938,645 | 3,649,522 | 3.4 M to 3.6 M (+6.84 %) |
Jun 29 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.04 | 96,673 | 390,250 | 3,415,877 | 3.3 M to 3.4 M (+2.91 %) |
Jun 29 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.03 | 1,072 | 4,320 | 3,319,204 | 3.3 M to 3.3 M (+0.03 %) |
Jun 27 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.00 | 103,552 | 414,374 | 3,318,132 | 3.2 M to 3.3 M (+3.22 %) |
Jun 27 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.07 | 26,145 | 106,342 | 3,214,580 | 3.2 M to 3.2 M (+0.82 %) |
Jun 27 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.05 | 15,005 | 60,797 | 3,188,435 | 3.2 M to 3.2 M (+0.47 %) |
Jun 27 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.06 | 8,239 | 33,459 | 3,173,430 | 3.2 M to 3.2 M (+0.26 %) |
Jun 21 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.07 | 36,983 | 150,643 | 3,165,191 | 3.1 M to 3.2 M (+1.18 %) |
Jun 21 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.00 | 21,409 | 85,561 | 3,128,208 | 3.1 M to 3.1 M (+0.69 %) |
Jun 21 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 3.99 | 27,367 | 109,235 | 3,106,799 | 3.1 M to 3.1 M (+0.89 %) |
Jun 21 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.00 | 23,585 | 94,290 | 3,079,432 | 3.1 M to 3.1 M (+0.77 %) |
Jun 21 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.00 | 6,361 | 25,417 | 3,055,847 | 3 M to 3.1 M (+0.21 %) |
Jun 13 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.04 | 29,202 | 118,107 | 3,049,486 | 3 M to 3 M (+0.97 %) |
Jun 13 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.02 | 39,543 | 158,809 | 3,020,284 | 3 M to 3 M (+1.33 %) |
Jun 13 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 3.90 | 18,491 | 72,115 | 2,980,741 | 3 M to 3 M (+0.62 %) |
Jun 13 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.00 | 1,393,286 | 5,573,144 | 2,962,250 | 1.6 M to 3 M (+88.80 %) |
Jun 13 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.11 | 53,921 | 221,615 | 1,568,964 | 1.5 M to 1.6 M (+3.56 %) |
Apr 28 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Option Exercise | J | 0.00 | 284,115 | 0 | 284,115 | |
Apr 28 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Option Exercise | J | 0.00 | 34,385 | 0 | 0 | |
Apr 28 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Option Exercise | J | 0.00 | 249,730 | 0 | 0 | |
Apr 28 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Option Exercise | J | 6.25 | 355,143 | 2,219,644 | 355,143 | |
Apr 28 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Option Exercise | J | 6.25 | 42,981 | 268,631 | 0 | |
Apr 28 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Option Exercise | J | 6.25 | 312,162 | 1,951,013 | 0 | |
Apr 28 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | J | 0.00 | 448,047 | 0 | 682,908 | 234.9 K to 682.9 K (+190.77 %) |
Apr 28 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Sell | J | 0.00 | 45,090 | 0 | 0 | 45.1 K to 0 (-100.00 %) |
Apr 28 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Sell | J | 0.00 | 49,807 | 0 | 0 | 49.8 K to 0 (-100.00 %) |
Apr 28 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Sell | J | 0.00 | 353,150 | 0 | 0 | 353.2 K to 0 (-100.00 %) |
Page: 1